(Q45875756)

17 December 2017

title

Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys (English)

1 reference

17 December 2017

0 references

0 references

Ohtani K

1

1 reference

17 December 2017

Usui M

2

1 reference

17 December 2017

Nakano K

3

1 reference

17 December 2017

Kohjimoto Y

4

1 reference

17 December 2017

Kitajima S

5

1 reference

17 December 2017

Hirouchi Y

6

1 reference

17 December 2017

Li XH

7

1 reference

17 December 2017

Kitamoto S

8

1 reference

17 December 2017

Takeshita A

9

1 reference

17 December 2017

Egashira K

10

1 reference

17 December 2017

publication date

1 August 2004

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

11

1 reference

17 December 2017

issue

16

1 reference

17 December 2017

page(s)

1273-1282

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302288

exact match

0 references

cites work

Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

New frontiers in interventional cardiology: intravascular radiation to prevent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

What is "the matter" with restenosis in 2002?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Inflammation and restenosis in the stent era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

21 January 2018

Chemokines and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

CCR2 deficiency decreases intimal hyperplasia after arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Endovascular stent design dictates experimental restenosis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Oral everolimus inhibits in-stent neointimal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Pathology of Acute and Chronic Coronary Stenting in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

Frontiers in interventional cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

Morphological predictors of restenosis after coronary stenting in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

Increase in circulating levels of monocyte chemoattractant protein-1 with aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302288

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302288

1 reference

17 December 2017

Dimensions Publication ID

1033551562

0 references

1 reference

17 December 2017